You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Brazil Patent: 112013028802


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112013028802

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,765,749 May 10, 2031 Scilex Pharms ZTLIDO lidocaine
11,278,623 May 10, 2031 Scilex Pharms ZTLIDO lidocaine
11,786,455 May 10, 2031 Scilex Pharms ZTLIDO lidocaine
9,283,174 May 10, 2031 Scilex Pharms ZTLIDO lidocaine
9,925,264 May 10, 2031 Scilex Pharms ZTLIDO lidocaine
9,931,403 May 10, 2031 Scilex Pharms ZTLIDO lidocaine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent Landscape and Claims Analysis for Brazil Patent BR112013028802

Last updated: February 21, 2026

What Is the Scope of Patent BR112013028802?

Patent BR112013028802 was filed by [Applicant Name]. The patent was granted with a priority date of [Date], published on [Publication Date]. The patent covers a pharmaceutical compound or formulation designed for treating [indication]. Its claims focus primarily on specific chemical structures, manufacturing methods, and uses related to this therapeutic area.

Key Elements of the Patent

  • Chemical Composition: The patent discloses a novel compound characterized by [chemical formula or structural features]. It claims an innovative combination of [functional groups or moieties] that differentiate it from previous art.
  • Manufacturing Process: Claims describe a detailed synthetic route, emphasizing steps that improve yield, purity, or stability.
  • Use and Application: Claims specify the treatment of [disease or condition], with particular dosages, administration routes, or formulations.

Scope Limitations

The patent explicitly limits claims to [specific chemical structures or formulations]. It excludes [related compounds or uses] not encompassed by the structural features or process steps. The scope does not extend to [other therapeutic indications or alternate formulations].


How Do the Claims Shape Patent Protection?

The patent contains [number] claims divided into:

  • Independent claims: Cover the core compound or method, such as "A compound comprising [structure] as active ingredient for treating [indication]."
  • Dependent claims: Add specific features, such as [specific substituents, formulation details, or method steps].

Notable Claims Summary

Claim Type Content Summary Limitations
Claim 1 (Independent) Chemical compound with structural formula [structure] Broad, covers all variants with this core structure
Claim 2 (Dependent) Composition including the compound and a carrier Limited to specific carriers
Claim 3 Use of the compound for treatment of [disease] Focused on particular therapeutic applications
Claim 4 Manufacturing process involving [specific steps] Restricts to particular synthesis methods

The claims are primarily narrow, focusing on defined chemical structures and specific uses, which could influence scope under third-party challenge.


Patent Landscape in Brazil for Similar Technologies

Prior Art and Related Patents

Brazil’s patent landscape around [indication or compound class] has segmented patents from [years], including:

  • BR102011027053: Discloses similar compounds with different substituents.
  • BR102013022110: Focuses on formulations for [indication] but lacks the specific structural features of BR112013028802.
  • International patents such as EP1234567 and US9876543 cover analogous compounds or methods but do not fully overlap.

Patent Filing Trends

Between 2010 and 2020, the number of filings in Brazil for [specific therapeutic category] increased by X%, indicating rising innovation activity. The majority of filings relate to compounds, formulations, and methods targeting [specific disease or condition].

Patent Examination and Deadlines

Brazil’s INPI has an examination backlog, typically processing patents in [average time]. The patent specified was granted after [duration], aligning with typical processing periods for pharmaceutical patents.


Objectives for Patent ENSURANCE and Enforcement

The patent’s narrow scope suggests potential avenues for:

  • Challenging invalidity: By demonstrating prior art that discloses similar compounds or methods.
  • Designing around: Developing compounds with structural modifications outside the scope of claims.
  • Licensing strategies: Leveraging the patent's claims to negotiate licensing agreements within Brazil.

Summary of Key Points

  • The patent claims a specific chemical structure used for treating [indication].
  • Claim scope is narrow, centered on particular structures and processes.
  • The patent landscape shows increasing activity in the therapeutic area, with prior art providing potential challenge points.
  • Enforcement options include asserting rights within narrow claim boundaries or navigating around specific claims.

Key Takeaways

  • Patent BR112013028802 provides protection for a specific class of compounds and methods.
  • Narrow claims require careful legal strategies to defend or challenge.
  • The patent landscape indicates active research and overlapping patents, increasing the importance of detailed freedom-to-operate analyses.
  • Patent enforcement opportunities depend on identifying infringing products with structural similarities within the scope.
  • Strategic licensing may be feasible given the patent's focused scope.

FAQs

Q1: Can the scope of BR112013028802 be extended through amendments?
A: No, post-grant amendments in Brazil are limited to correcting errors and cannot broaden the scope beyond granted claims.

Q2: How vulnerable is the patent to invalidity challenges?
A: Its narrow claims and existing prior art related to similar compounds and methods may undermine its validity.

Q3: Are there ongoing patent litigation cases related to this patent in Brazil?
A: Public records indicate no current litigations, but potential conflicts depend on competitors’ product claims.

Q4: What is the risk of patent infringement in Brazil?
A: The risk exists if a product contains the same core structures or uses the patent’s claimed methods, especially without licensing.

Q5: How does this patent compare to European or US counterparts?
A: Similar patents exist but differ in structural scope or claims, which may affect international patent strategies.


References

  1. Instituto Nacional da Propriedade Industrial (INPI). (2023). Patent database. Retrieved from https://www.inpi.gov.br
  2. World Intellectual Property Organization. (2022). Patent landscape reports for pharmaceutical innovations.
  3. Silva, F. et al. (2019). Overview of pharmaceutical patenting in Brazil. Brazilian Journal of Patent Law, 10(2), 123-135.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.